Alnylam Pharmaceuticals
ALNY
#650
Rank
$30.21 B
Marketcap
$234.28
Share price
0.28%
Change (1 day)
21.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $300.55 USD on 2024-10-16

Lowest end of day price: $3.95 USD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$19.79 0.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$718.15 0.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$126.29 1.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.48 2.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.61 3.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$97.64 0.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$48.15-0.08%๐Ÿ‡ซ๐Ÿ‡ท France
$21.24-0.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel